<?xml version="1.0" encoding="UTF-8"?><rss version="2.0"><channel><title>albendazole</title><link>http://www.unboundmedicine.com/medline/ebm/research/albendazole</link><description>Unbound MEDLINE is a service provided by Unbound Medicine, Inc. that includes data and services from the U.S. National Library of Medicine's MEDLINE® and PubMed® databases.</description><language>en-us</language><copyright>Unbound Medicine, Inc.</copyright><item><title>Identification of Novel Substrates for Human Cytochrome P450 2J2.</title><link>http://www.unboundmedicine.com/medline/ebm/record/19923256/full_citation/Identification_of_Novel_Substrates_for_Human_Cytochrome_P450_2J2_</link><description>Lee CA, Neul D, Clouser-Roche A, et al. <br/><span class="title">Identification of Novel Substrates for Human Cytochrome P450 2J2. [JOURNAL ARTICLE]</span><br/><span class="source" title="Drug metabolism and disposition: the biological fate of chemicals">Drug Metab Dispos 2009 Nov 18.</span><br/> <a href="http://www.unboundmedicine.com/medline/ebm/record/19923256/abstract/Identification_of_Novel_Substrates_for_Human_Cytochrome_P450_2J2_">Abstract</a> | <a href="http://www.unboundmedicine.com/medline/ebm/record/19923256/full_citation/Identification_of_Novel_Substrates_for_Human_Cytochrome_P450_2J2_">Full Citation</a> | <a rel="nofollow" href="http://www.unboundmedicine.com/medline/ebm/related/19923256/Identification_of_Novel_Substrates_for_Human_Cytochrome_P450_2J2_">Find Related Articles</a> </description></item><item><title>Unusual presentation of orbital cysticercosis-ptosis, diminution of vision and medial rectus weakness: a case report.</title><link>http://www.unboundmedicine.com/medline/ebm/record/19918504/full_citation/Unusual_presentation_of_orbital_cysticercosis_ptosis_diminution_of_vision_and_medial_rectus_weakness:_a_case_report_</link><description>Taksande B, Jajoo U, Yelwatkar S, et al. <br/><span class="title">Unusual presentation of orbital cysticercosis-ptosis, diminution of vision and medial rectus weakness: a case report. [Journal Article]</span><br/><span class="source" title="Cases journal">Cases J 2009.:7025.</span><br/> <a href="http://www.unboundmedicine.com/medline/ebm/record/19918504/abstract/Unusual_presentation_of_orbital_cysticercosis_ptosis_diminution_of_vision_and_medial_rectus_weakness:_a_case_report_">Abstract</a> | <a href="http://www.unboundmedicine.com/medline/ebm/record/19918504/full_citation/Unusual_presentation_of_orbital_cysticercosis_ptosis_diminution_of_vision_and_medial_rectus_weakness:_a_case_report_">Full Citation</a></description></item><item><title>Albendazole and its metabolites in the breast milk of lactating women following a single oral dose of albendazole.</title><link>http://www.unboundmedicine.com/medline/ebm/record/19916998/full_citation/Albendazole_and_its_metabolites_in_the_breast_milk_of_lactating_women_following_a_single_oral_dose_of_albendazole_</link><description>Abdel-tawab AM, Bradley M, Ghazaly EA, et al. <br/><span class="title">Albendazole and its metabolites in the breast milk of lactating women following a single oral dose of albendazole. [Journal Article, Research Support, Non-U.S. Gov't]</span><br/><span class="source" title="British journal of clinical pharmacology">Br J Clin Pharmacol 2009 Nov; 68(5):737-42.</span><br/> <a href="http://www.unboundmedicine.com/medline/ebm/record/19916998/abstract/Albendazole_and_its_metabolites_in_the_breast_milk_of_lactating_women_following_a_single_oral_dose_of_albendazole_">Abstract</a> | <a href="http://www.unboundmedicine.com/medline/ebm/record/19916998/full_citation/Albendazole_and_its_metabolites_in_the_breast_milk_of_lactating_women_following_a_single_oral_dose_of_albendazole_">Full Citation</a> | <a href="http://www3.interscience.wiley.com/resolve/openurl%3fgenre=article%26amp;sid=nlm:pubmed%26amp;issn=0306-5251%26amp;date=2009%26amp;volume=68%26amp;issue=5%26amp;spage=737">Publisher Full Text</a> | <a rel="nofollow" href="http://www.unboundmedicine.com/medline/ebm/related/19916998/Albendazole_and_its_metabolites_in_the_breast_milk_of_lactating_women_following_a_single_oral_dose_of_albendazole_">Find Related Articles</a> </description></item><item><title>Personalized management of patients with inoperable alveolar echinococcosis undergoing treatment with albendazole: usefulness of positron-emission-tomography combined with serological and computed tomography follow-up.</title><link>http://www.unboundmedicine.com/medline/ebm/record/19912267/full_citation/Personalized_management_of_patients_with_inoperable_alveolar_echinococcosis_undergoing_treatment_with_albendazole:_usefulness_of_positron_emission_tomography_combined_with_serological_and_computed_tomography_follow_up_</link><description>Crouzet J, Grenouillet F, Delabrousse E, et al. <br/><span class="title">Personalized management of patients with inoperable alveolar echinococcosis undergoing treatment with albendazole: usefulness of positron-emission-tomography combined with serological and computed tomography follow-up. [JOURNAL ARTICLE]</span><br/><span class="source" title="Clinical microbiology and infection : the official publication of the European Society of Clinical Microbiology and Infectious Diseases">Clin Microbiol Infect 2009 Nov 13.</span><br/> <a href="http://www.unboundmedicine.com/medline/ebm/record/19912267/abstract/Personalized_management_of_patients_with_inoperable_alveolar_echinococcosis_undergoing_treatment_with_albendazole:_usefulness_of_positron_emission_tomography_combined_with_serological_and_computed_tomography_follow_up_">Abstract</a> | <a href="http://www.unboundmedicine.com/medline/ebm/record/19912267/full_citation/Personalized_management_of_patients_with_inoperable_alveolar_echinococcosis_undergoing_treatment_with_albendazole:_usefulness_of_positron_emission_tomography_combined_with_serological_and_computed_tomography_follow_up_">Full Citation</a> | <a rel="nofollow" href="http://www.unboundmedicine.com/medline/ebm/related/19912267/Personalized_management_of_patients_with_inoperable_alveolar_echinococcosis_undergoing_treatment_with_albendazole:_usefulness_of_positron_emission_tomography_combined_with_serological_and_computed_tomography_follow_up_">Find Related Articles</a> </description></item><item><title>Determination of Benzimidazole Residues in Edible Animal Food by Polymer Monolith Microextraction Combined with Liquid Chromatography-Mass Spectrometry.</title><link>http://www.unboundmedicine.com/medline/ebm/record/19911834/full_citation/Determination_of_Benzimidazole_Residues_in_Edible_Animal_Food_by_Polymer_Monolith_Microextraction_Combined_with_Liquid_Chromatography_Mass_Spectrometry_</link><description>Hu XZ, Wang JX, Feng YQ <br/><span class="title">Determination of Benzimidazole Residues in Edible Animal Food by Polymer Monolith Microextraction Combined with Liquid Chromatography-Mass Spectrometry. [JOURNAL ARTICLE]</span><br/><span class="source" title="Journal of agricultural and food chemistry">J Agric Food Chem 2009 Nov 13.</span><br/> <a href="http://www.unboundmedicine.com/medline/ebm/record/19911834/abstract/Determination_of_Benzimidazole_Residues_in_Edible_Animal_Food_by_Polymer_Monolith_Microextraction_Combined_with_Liquid_Chromatography_Mass_Spectrometry_">Abstract</a> | <a href="http://www.unboundmedicine.com/medline/ebm/record/19911834/full_citation/Determination_of_Benzimidazole_Residues_in_Edible_Animal_Food_by_Polymer_Monolith_Microextraction_Combined_with_Liquid_Chromatography_Mass_Spectrometry_">Full Citation</a> | <a rel="nofollow" href="http://www.unboundmedicine.com/medline/ebm/related/19911834/Determination_of_Benzimidazole_Residues_in_Edible_Animal_Food_by_Polymer_Monolith_Microextraction_Combined_with_Liquid_Chromatography_Mass_Spectrometry_">Find Related Articles</a> </description></item><item><title>Phase I clinical trial to determine maximum tolerated dose of oral albendazole in patients with advanced cancer.</title><link>http://www.unboundmedicine.com/medline/ebm/record/19904538/full_citation/Phase_I_clinical_trial_to_determine_maximum_tolerated_dose_of_oral_albendazole_in_patients_with_advanced_cancer_</link><description>Pourgholami MH, Szwajcer M, Chin M, et al. <br/><span class="title">Phase I clinical trial to determine maximum tolerated dose of oral albendazole in patients with advanced cancer. [JOURNAL ARTICLE]</span><br/><span class="source" title="Cancer chemotherapy and pharmacology">Cancer Chemother Pharmacol 2009 Nov 11.</span><br/> <a href="http://www.unboundmedicine.com/medline/ebm/record/19904538/abstract/Phase_I_clinical_trial_to_determine_maximum_tolerated_dose_of_oral_albendazole_in_patients_with_advanced_cancer_">Abstract</a> | <a href="http://www.unboundmedicine.com/medline/ebm/record/19904538/full_citation/Phase_I_clinical_trial_to_determine_maximum_tolerated_dose_of_oral_albendazole_in_patients_with_advanced_cancer_">Full Citation</a> | <a rel="nofollow" href="http://www.unboundmedicine.com/medline/ebm/related/19904538/Phase_I_clinical_trial_to_determine_maximum_tolerated_dose_of_oral_albendazole_in_patients_with_advanced_cancer_">Find Related Articles</a> </description></item><item><title>The identification of cattle nematode parasites resistant to multiple classes of anthelmintics in a commercial cattle population in the US.</title><link>http://www.unboundmedicine.com/medline/ebm/record/19900760/full_citation/The_identification_of_cattle_nematode_parasites_resistant_to_multiple_classes_of_anthelmintics_in_a_commercial_cattle_population_in_the_US_</link><description>Gasbarre LC, Smith LL, Lichtenfels JR, et al. <br/><span class="title">The identification of cattle nematode parasites resistant to multiple classes of anthelmintics in a commercial cattle population in the US. [JOURNAL ARTICLE]</span><br/><span class="source" title="Veterinary parasitology">Vet Parasitol 2009 Aug 26.</span><br/> <a href="http://www.unboundmedicine.com/medline/ebm/record/19900760/abstract/The_identification_of_cattle_nematode_parasites_resistant_to_multiple_classes_of_anthelmintics_in_a_commercial_cattle_population_in_the_US_">Abstract</a> | <a href="http://www.unboundmedicine.com/medline/ebm/record/19900760/full_citation/The_identification_of_cattle_nematode_parasites_resistant_to_multiple_classes_of_anthelmintics_in_a_commercial_cattle_population_in_the_US_">Full Citation</a> | <a rel="nofollow" href="http://www.unboundmedicine.com/medline/ebm/related/19900760/The_identification_of_cattle_nematode_parasites_resistant_to_multiple_classes_of_anthelmintics_in_a_commercial_cattle_population_in_the_US_">Find Related Articles</a> </description></item><item><title>The development of albendazole for lymphatic filariasis.</title><link>http://www.unboundmedicine.com/medline/ebm/record/19843396/full_citation/The_development_of_albendazole_for_lymphatic_filariasis_</link><description>Horton J <br/><span class="title">The development of albendazole for lymphatic filariasis. [Journal Article]</span><br/><span class="source" title="Annals of tropical medicine and parasitology">Ann Trop Med Parasitol 2009 Oct.:S33-40.</span><br/> <a href="http://www.unboundmedicine.com/medline/ebm/record/19843396/abstract/The_development_of_albendazole_for_lymphatic_filariasis_">Abstract</a> | <a href="http://www.unboundmedicine.com/medline/ebm/record/19843396/full_citation/The_development_of_albendazole_for_lymphatic_filariasis_">Full Citation</a> | <a rel="nofollow" href="http://www.unboundmedicine.com/medline/ebm/related/19843396/The_development_of_albendazole_for_lymphatic_filariasis_">Find Related Articles</a> </description></item><item><title>The Global Programme to Eliminate Lymphatic Filariasis: health impact during its first 8 years (2000-2007).</title><link>http://www.unboundmedicine.com/medline/ebm/record/19843394/full_citation/The_Global_Programme_to_Eliminate_Lymphatic_Filariasis:_health_impact_during_its_first_8_years__2000_2007__</link><description>Hooper PJ, Bradley MH, Biswas G, et al. <br/><span class="title">The Global Programme to Eliminate Lymphatic Filariasis: health impact during its first 8 years (2000-2007). [Journal Article]</span><br/><span class="source" title="Annals of tropical medicine and parasitology">Ann Trop Med Parasitol 2009 Oct.:S17-21.</span><br/> <a href="http://www.unboundmedicine.com/medline/ebm/record/19843394/abstract/The_Global_Programme_to_Eliminate_Lymphatic_Filariasis:_health_impact_during_its_first_8_years__2000_2007__">Abstract</a> | <a href="http://www.unboundmedicine.com/medline/ebm/record/19843394/full_citation/The_Global_Programme_to_Eliminate_Lymphatic_Filariasis:_health_impact_during_its_first_8_years__2000_2007__">Full Citation</a> | <a rel="nofollow" href="http://www.unboundmedicine.com/medline/ebm/related/19843394/The_Global_Programme_to_Eliminate_Lymphatic_Filariasis:_health_impact_during_its_first_8_years__2000_2007__">Find Related Articles</a> </description></item><item><title>GlaxoSmithKline and Merck: private-sector collaboration for the elimination of lymphatic filariasis.</title><link>http://www.unboundmedicine.com/medline/ebm/record/19843393/full_citation/GlaxoSmithKline_and_Merck:_private_sector_collaboration_for_the_elimination_of_lymphatic_filariasis_</link><description>Gustavsen KM, Bradley MH, Wright AL <br/><span class="title">GlaxoSmithKline and Merck: private-sector collaboration for the elimination of lymphatic filariasis. [Journal Article]</span><br/><span class="source" title="Annals of tropical medicine and parasitology">Ann Trop Med Parasitol 2009 Oct.:S11-5.</span><br/> <a href="http://www.unboundmedicine.com/medline/ebm/record/19843393/abstract/GlaxoSmithKline_and_Merck:_private_sector_collaboration_for_the_elimination_of_lymphatic_filariasis_">Abstract</a> | <a href="http://www.unboundmedicine.com/medline/ebm/record/19843393/full_citation/GlaxoSmithKline_and_Merck:_private_sector_collaboration_for_the_elimination_of_lymphatic_filariasis_">Full Citation</a> | <a rel="nofollow" href="http://www.unboundmedicine.com/medline/ebm/related/19843393/GlaxoSmithKline_and_Merck:_private_sector_collaboration_for_the_elimination_of_lymphatic_filariasis_">Find Related Articles</a> </description></item></channel></rss>